【港股异动 | 和黄医药(00013.HK)午后涨幅扩大逾15% 与GSK就KRAS-EGFR抗体偶联癌症药物达成许可协议】智通财经APP获悉,和黄医药(00013.HK)午后涨幅扩大逾15%,截至发稿,涨12.23%,报21.46港元,成交额3.69亿港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.